Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
238lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Learning paths
Pick a track — progress rings update as you complete lessons.
4 lessons
9mProtocolsIntermediate
MariTide Dosing Guide: Once-Monthly 140–420 mg Phase 2 Map
MariTide is the once-monthly obesity candidate people keep comparing to weekly GLP-1s. Here's the Phase 2 dosing map — 140 / 280 / 420 mg and the escalation arms that mattered for tolerability.
8mSafetyIntermediate
MariTide Beginner's Guide: What Maridebart Cafraglutide Is
MariTide is Amgen's once-monthly obesity candidate. This beginner guide covers the mechanism framing, Phase 2 headlines, and what serious trackers should log.
8mProtocolsIntermediate
MariTide vs Weekly GLP-1s: Monthly Conjugate vs Weekly Agonists
Weekly vs monthly is the real MariTide comparison. Here's how Amgen's conjugate stacks up conceptually against weekly dual/triple agonists — without fake head-to-heads.
7mSafetyIntermediate
MariTide Side Effects: GI Tolerability and Monthly Titration
Monthly conjugates can pack a bigger post-dose GI window. Here's how to think about MariTide tolerability using Phase 2 lessons — without fear content.
Also available at /blog for legacy links.